Monarch Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-17,200
| Closed | -$571K | – | 94 |
|
|
2017
Q2 | $571K | Hold |
17,200
| – | – | 0.22% | 69 |
|
|
2017
Q1 | $552K | Sell |
17,200
-5
| -0% | -$160 | 0.2% | 68 |
|
|
2016
Q4 | $624K | Sell |
17,205
-435
| -2% | -$15.8K | 0.23% | 68 |
|
|
2016
Q3 | $812K | Buy |
17,640
+50
| +0.3% | +$2.3K | 0.31% | 64 |
|
|
2016
Q2 | $884K | Buy |
17,590
+1,505
| +9% | +$75.6K | 0.33% | 62 |
|
|
2016
Q1 | $861K | Buy |
16,085
+835
| +5% | +$44.7K | 0.31% | 63 |
|
|
2015
Q4 | $1M | Hold |
15,250
| – | – | 0.38% | 60 |
|
|
2015
Q3 | $861K | Buy |
15,250
+398
| +3% | +$22.5K | 0.35% | 61 |
|
|
2015
Q2 | $878K | Buy |
14,852
+652
| +5% | +$38.5K | 0.34% | 63 |
|
|
2015
Q1 | $885K | Buy |
14,200
+250
| +2% | +$15.6K | 0.33% | 62 |
|
|
2014
Q4 | $802K | Buy |
13,950
+400
| +3% | +$23K | 0.3% | 66 |
|
|
2014
Q3 | $728K | Buy |
13,550
+1,700
| +14% | +$91.3K | 0.29% | 66 |
|
|
2014
Q2 | $621K | Buy |
11,850
+150
| +1% | +$7.86K | 0.24% | 67 |
|
|
2014
Q1 | $618K | Buy |
11,700
+750
| +7% | +$39.6K | 0.24% | 66 |
|
|
2013
Q4 | $439K | Buy |
10,950
+1,750
| +19% | +$70.2K | 0.17% | 72 |
|
|
2013
Q3 | $348K | Buy |
9,200
+1,600
| +21% | +$60.5K | 0.15% | 76 |
|
|
2013
Q2 | $298K | Buy |
+7,600
| New | +$298K | 0.13% | 80 |
|